Advantage Austria Show navigation

Pfizer Enters into Agreement to Acquire Baxter’s Portfolio Of Marketed Vaccines

July 30, 2014

Portion of Baxter’s facility in Orth, Austria also acquired

Pfizer Inc. announced on July 30, 2014 that it has entered into a definitive agreement to acquire Baxter International Inc.’s portfolio of marketed vaccines for USD 635 million. As part of the transaction, Pfizer will also acquire a portion of Baxter’s facility in Orth, Austria, where these vaccines are manufactured.

For more details, read the press release here .

print
©©ADVANTAGE AUSTRIA